Associations between longitudinal changes in sleep disturbance and depressive and anxiety symptoms during the COVID-19 virus pandemic among older women with and without breast cancer in the thinking and living with breast cancer study
- PMID: 35315588
- PMCID: PMC9110906
- DOI: 10.1002/cam4.4682
Associations between longitudinal changes in sleep disturbance and depressive and anxiety symptoms during the COVID-19 virus pandemic among older women with and without breast cancer in the thinking and living with breast cancer study
Abstract
Purpose: Several studies have reported sleep disturbances during the COVID-19 virus pandemic. Little data exist about the impact of the pandemic on sleep and mental health among older women with breast cancer. We sought to examine whether women with and without breast cancer who experienced new sleep problems during the pandemic had worsening depression and anxiety.
Methods: Breast cancer survivors aged ≥60 years with a history of nonmetastatic breast cancer (n = 242) and frequency-matched noncancer controls (n = 158) active in a longitudinal cohort study completed a COVID-19 virus pandemic survey from May to September 2020 (response rate 83%). Incident sleep disturbance was measured using the restless sleep item from the Center for Epidemiological Studies-Depression Scale (CES-D). CES-D score (minus the sleep item) captured depressive symptoms; the State-Anxiety subscale of the State Trait Anxiety Inventory measured anxiety symptoms. Multivariable linear regression models examined how the development of sleep disturbance affected changes in depressive or anxiety symptoms from the most recent prepandemic survey to the pandemic survey, controlling for covariates.
Results: The prevalence of sleep disturbance during the pandemic was 22.3%, with incident sleep disturbance in 10% and 13.5% of survivors and controls, respectively. Depressive and anxiety symptoms significantly increased during the pandemic among women with incident sleep disturbance (vs. no disturbance) (β = 8.16, p < 0.01 and β = 6.14, p < 0.01, respectively), but there were no survivor-control differences in the effect.
Conclusion: Development of sleep disturbances during the COVID-19 virus pandemic may negatively affect older women's mental health, but breast cancer survivors diagnosed with the nonmetastatic disease had similar experiences as women without cancer.
Trial registration: ClinicalTrials.gov NCT03451383.
Keywords: behavioral science; breast cancer; epidemiology; psychosocial studies.
© 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
Author Dilawari served on the Oncology Summit Advisory Board for Cardinal Health. Author Jim has consulted for RedHill BioPharma, Janssen Scientific Affairs, and Merck and has received grant funding from Kite Pharma. All other authors declare no conflicts.
Figures
References
-
- Partinen M, Bjorvatn B, Holzinger B, et al. Sleep and circadian problems during the coronavirus disease 2019 (COVID‐19) pandemic: the international COVID‐19 sleep study (ICOSS). J Sleep Res. 2020;30(1):e13206. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
- U54 CA137788/CA/NCI NIH HHS/United States
- K01 CA212056/CA/NCI NIH HHS/United States
- R01 CA244673/CA/NCI NIH HHS/United States
- K08 CA241337/CA/NCI NIH HHS/United States
- P30 CA008748/CA/NCI NIH HHS/United States
- R01 CA129769/CA/NCI NIH HHS/United States
- K01 AG065485/AG/NIA NIH HHS/United States
- P30 AG072976/AG/NIA NIH HHS/United States
- P30 AG010133/AG/NIA NIH HHS/United States
- R01 CA172119/CA/NCI NIH HHS/United States
- R01 AG068193/AG/NIA NIH HHS/United States
- P30 AG028716/AG/NIA NIH HHS/United States
- R35 CA197289/CA/NCI NIH HHS/United States
- K12 HD001441/HD/NICHD NIH HHS/United States
